Eduardo Agosin
Co-Founder & CTO of Sticta Biologicals
Eduardo is the co-founder and Chief Technology Officer of Sticta Biologicals, a Chilean precision fermentation company founded in 2021. The company is committed to democratizing the consumption of cultivated meats and fostering their widespread adoption for the benefit of our planet. We offer cultivated meat companies Smart-insulin, a food-grade, thermostable single-chain insulin that has been validated across a range of mammalian cell lines, along with species-specific transferrin.
Furthermore, Sticta contributes to the cultivated meat industry by providing a dynamic genome-scale metabolic model of porcine cells. This model was developed with support from GFI, Meatable and the Center for Mathematical Modeling at the University of Chile. It helps identify optimal targets for enhancing metabolic pathways, process conditions, and culture components, which ultimately leads to increased cell densities and accelerated proliferation of cultivated meat cells.
Eduardo is a bioengineer trained at the Catholic University of Louvain-la-Neuve, Belgium, holding a PhD in industrial microbiology from AgroParisTech, France. He served as a biotechnology professor at the Catholic University of Chile for three decades, publishing over 130 scientific papers on metabolic engineering and precision fermentation, while holding 12 patents. Eduardo has been a visiting professor at prestigious institutions, including MIT (USA), DTU (Denmark), and the University of Bordeaux (France). As an experienced entrepreneur, he founded and later sold three startups before establishing.


